Grifols (GIKLY) Equity Ratio (2009 - 2025)
Grifols (GIKLY) posted Equity Ratio of 0.27 for Q4 2025, down 2.71% quarter-over-quarter from 0.27 in Q4 2024, and down 2.71% year-on-year from 0.27 in Q4 2024.
Grifols (GIKLY) Equity Ratio (2009 - 2025) Analysis & Trends
Grifols (GIKLY) has reported Equity Ratio for 16 consecutive years, with 0.27 the latest figure, recorded in Q4 2025.
- Equity Ratio for Q4 2025 came in at 0.27, down 2.71% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.27 (down 2.71% YoY), and the FY2025 annual result was 0.27, up 177.36% from the prior year.
- Equity Ratio was 0.27 for Q4 2025 at Grifols, down from 0.27 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.38 in Q4 2022 and troughed at 0.27 in Q4 2025.
- Average Equity Ratio over 5 years is 0.33, with a median of 0.36 recorded in 2021.
- Year-over-year, Equity Ratio jumped 1291.88% in 2021 and fell 23.21% in 2024.
- Over 5 years, Equity Ratio stood at 0.36 in 2021, then gained by 5.37% to 0.38 in 2022, then retreated by 4.75% to 0.36 in 2023, then dropped by 23.21% to 0.27 in 2024, then declined by 2.71% to 0.27 in 2025.
- Per Business Quant data, the three most recent Equity Ratio figures were 0.27 in Q4 2025, 0.27 in Q4 2024, and 0.36 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.27 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.40 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -0.05 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.36 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.10 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.42 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.43 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | 0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.36 |
| Dec 31, 2022 | 0.38 |
| Dec 31, 2021 | 0.36 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.44 |
| Dec 31, 2018 | 0.38 |
| Jun 30, 2018 | 0.35 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.33 |
| Jun 30, 2017 | 0.32 |
| Dec 31, 2016 | 0.37 |
| Sep 30, 2016 | 0.37 |
| Jun 30, 2016 | 0.36 |
| Dec 31, 2015 | 0.34 |
| Sep 30, 2015 | 0.35 |
| Mar 31, 2015 | 0.33 |